These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

595 related items for PubMed ID: 3109430

  • 1. Effects of different monoamine oxidase inhibitors on the metabolism of L-dopa in the rat brain.
    Nguyen TB, Angers M.
    Biochem Pharmacol; 1987 May 15; 36(10):1731-5. PubMed ID: 3109430
    [Abstract] [Full Text] [Related]

  • 2. L-3,4-dihydroxyphenylalanine-induced dopamine release in the striatum of intact and 6-hydroxydopamine-treated rats: differential effects of monoamine oxidase A and B inhibitors.
    Wachtel SR, Abercrombie ED.
    J Neurochem; 1994 Jul 15; 63(1):108-17. PubMed ID: 8207420
    [Abstract] [Full Text] [Related]

  • 3. Modification of dopamine and norepinephrine metabolism in the rat brain by monoamine oxidase inhibitors.
    Buu NT, Angers M, Duhaime J, Kuchel O.
    J Neural Transm; 1987 Jul 15; 70(1-2):39-50. PubMed ID: 3668521
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Influence of selective inhibition of monoamine oxidase A or B on striatal metabolism of L-DOPA in hemiparkinsonian rats.
    Finberg JP, Wang J, Goldstein DS, Kopin IJ, Bankiewicz KS.
    J Neurochem; 1995 Sep 15; 65(3):1213-20. PubMed ID: 7643100
    [Abstract] [Full Text] [Related]

  • 6. In vivo comparison of the effects of inhibition of MAO-A versus MAO-B on striatal L-DOPA and dopamine metabolism.
    Brannan T, Prikhojan A, Martínez-Tica J, Yahr MD.
    J Neural Transm Park Dis Dement Sect; 1995 Sep 15; 10(2-3):79-89. PubMed ID: 9620056
    [Abstract] [Full Text] [Related]

  • 7. Type A monoamine oxidase catalyzes the intraneuronal deamination of dopamine within nigrostriatal, mesolimbic, tuberoinfundibular and tuberohypophyseal neurons in the rat.
    Demarest KT, Moore KE.
    J Neural Transm; 1981 Sep 15; 52(3):175-87. PubMed ID: 6796650
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Deamination of norepinephrine, dopamine, and serotonin by type A monoamine oxidase in discrete regions of the rat brain and inhibition by RS-8359.
    Kumagae Y, Matsui Y, Iwata N.
    Jpn J Pharmacol; 1991 Jan 15; 55(1):121-8. PubMed ID: 1904113
    [Abstract] [Full Text] [Related]

  • 12. In vivo studies on the effect of monoamine oxidase inhibitors on dopamine and serotonin metabolism in rat brain areas.
    Clement HW, Grote C, Wesemann W.
    J Neural Transm Suppl; 1990 Jan 15; 32():85-8. PubMed ID: 2128514
    [No Abstract] [Full Text] [Related]

  • 13. Dopamine produced from L-DOPA is degraded by endogenous monoamine oxidase in neurons of the dorsal raphe nucleus of the rat: an immunohistochemical study.
    Arai R, Karasawa N, Nagatsu I.
    Brain Res; 1996 May 25; 722(1-2):181-4. PubMed ID: 8813364
    [Abstract] [Full Text] [Related]

  • 14. Brain dialysis: in vivo metabolism of dopamine and serotonin by monoamine oxidase A but not B in the striatum of unrestrained rats.
    Kato T, Dong B, Ishii K, Kinemuchi H.
    J Neurochem; 1986 Apr 25; 46(4):1277-82. PubMed ID: 2419508
    [Abstract] [Full Text] [Related]

  • 15. Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea-pig.
    Ilani T, Lamensdorf I, Finberg JP.
    Br J Pharmacol; 2000 Aug 25; 130(8):1992-8. PubMed ID: 10952692
    [Abstract] [Full Text] [Related]

  • 16. Consequences of monoamine oxidase inhibition: increased vesicular accumulation of dopamine and norepinephrine and increased metabolism by catechol-O-methyltransferase and phenolsulfotransferase.
    Buu NT, Lussier C.
    Prog Neuropsychopharmacol Biol Psychiatry; 1989 Aug 25; 13(3-4):563-8. PubMed ID: 2748880
    [Abstract] [Full Text] [Related]

  • 17. Comparison of short and long-lasting effects of pargyline on cerebral dopamine metabolism.
    Waldmeier PC, Maître L.
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Aug 25; 294(2):133-40. PubMed ID: 1012333
    [Abstract] [Full Text] [Related]

  • 18. Reciprocal changes in striatal dopamine and beta-phenylethylamine induced by reserpine in the presence of monoamine oxidase inhibitors.
    Juorio AV, Greenshaw AJ, Wishart TB.
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Dec 25; 338(6):644-8. PubMed ID: 3149722
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of monoamine oxidase-B by (-)-deprenyl potentiates neuronal responses to dopamine agonists but does not inhibit dopamine catabolism in the rat striatum.
    Paterson IA, Juorio AV, Berry MD, Zhu MY.
    J Pharmacol Exp Ther; 1991 Sep 25; 258(3):1019-26. PubMed ID: 1679846
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.